You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 91 No. 4, October 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Studies of Trasylol

Evaluation of Trasylol Against the Hypotensive Effects of Trypsin and Kallikrein

LOKENDRA M. SINGH, MD; JOHN M. HOWARD, MD

AMA Arch Surg. 1965;91(4):635-639.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

WHATEVER the precipitating cause may be, enzymatic digestion of the pancreatic tissue by proteolytic enzymes is probably a factor in the pathogenesis of acute pancreatitis. The vascular collapse which sometimes occurs with acute pancreatitis may be attributable in part to vasoactive substances of the blood, activated by trypsin or kallikrein which enter the blood from the damaged pancreas.1 Therefore "the aim of the treatment of acute pancreatitis," according to Forell,2 "is to keep the enzyme content of the gland as low as possible, to inactivate the already active trypsin and kallikrein in the pancreas and blood, and finally to stop the intrapancreatic trypsin activation."

Several protease inhibitors, especially inhibitors of trypsin such as soybean inhibitors, Ovomucoid,3-6 benzethonium chloride, and even serum albumin8 have been used in efforts to modify the course of experimental pancreatitis but with limited or no success. Beneficial effects of a kallikrein and . . . [Full Text PDF of this Article]


Author Affiliations

PHILADELPHIA

From the Department of Surgery, Hahnemann Medical College.


Footnotes

Received for publication Jan 23, 1965.

Reprint requests to Department of Surgery, Hahnemann Medical College and Hospital, 230 N Broad St, Philadelphia 19102 (Dr. Howard).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.